Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Platelet-rich plasma and triamcinolone acetonide combined compound for strain diseases and preparation method thereof

A technology of platelet-rich plasma and triamcinolone acetonide, applied in the field of rehabilitation medical beauty, can solve problems such as destruction of collagen production, white blood cell residue, influence, etc., and achieve the effect of reducing the production of pro-inflammatory factors and controlling the inflammatory response

Pending Publication Date: 2020-03-06
四川世纪长青干细胞生物科技发展有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, during the preparation process of PRP, more or less white blood cells will remain. After injection, the white blood cells will participate in the inflammatory reaction, release inflammatory mediators such as IL-6, increase the risk of local inflammatory reactions, affect and destroy collagen production, and lead to Damage repair hindered

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Platelet-rich plasma and triamcinolone acetonide combined compound for strain diseases and preparation method thereof
  • Platelet-rich plasma and triamcinolone acetonide combined compound for strain diseases and preparation method thereof
  • Platelet-rich plasma and triamcinolone acetonide combined compound for strain diseases and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0021] The invention also discloses a preparation method of platelet-rich plasma combined with triamcinolone acetonide complex for strain-related diseases, which includes the following steps:

[0022] Step 1. Weighing: Weigh platelet-rich plasma and triamcinolone acetonide injection with a volume-to-mass ratio (ml / mg) of 2-6:10-40;

[0023] Step 2. The platelet-rich plasma and triamcinolone acetonide injection were mixed to prepare a complex of platelet-rich plasma combined with triamcinolone acetonide injection.

[0024] See the following specific examples:

Embodiment 1

[0026] Platelet-rich plasma combined with triamcinolone acetonide complex for strain-related diseases, including platelet-rich plasma and triamcinolone acetonide injection with a volume-to-mass ratio (ml / mg) of 4:20, preferably platelet-rich plasma 4ml, triamcinolone acetonide Injection 20mg.

[0027] The preparation method comprises: weighing platelet-rich plasma and triamcinolone acetonide injection according to the above; mixing platelet-rich plasma and triamcinolone acetonide injection to prepare platelet-rich plasma combined with triamcinolone acetonide injection compound.

Embodiment 2

[0029] Platelet-rich plasma combined with triamcinolone acetonide complex for strain-related diseases, including platelet-rich plasma and triamcinolone acetonide injection with a volume-to-mass ratio (ml / mg) of 2:40, preferably platelet-rich plasma 2ml, triamcinolone acetonide Injection 40mg.

[0030] The preparation method comprises: weighing platelet-rich plasma and triamcinolone acetonide injection according to the above; mixing platelet-rich plasma and triamcinolone acetonide injection to prepare platelet-rich plasma combined with triamcinolone acetonide injection compound.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a platelet-rich plasma and triamcinolone acetonide injection compound and a preparation method thereof. The compound comprises platelet-rich plasma and a triamcinolone acetonide injection in a volume-to-mass ratio (ml / mg) of (2-6): (10-40). The compound provided by the invention can obviously enhance the effect of the medicine and obviously reduce the inflammatory reaction,and is simple and feasible, quick in effect, high in effective rate and low in side effect.

Description

technical field [0001] The invention belongs to the technical field of rehabilitation medical cosmetology, and in particular relates to a complex of platelet-rich plasma combined with triamcinolone acetonide for strain-related diseases and a preparation method thereof. Background technique [0002] Platelet-rich plasma, English Platelet-Rich Plasma, abbreviated as PRP, is rich in 9 types of growth factors, such as platelet-derived growth factor (PDGF), transforming growth factor-β (TGF-β), insulin-like growth factor (IGF) , epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), etc. After PRP is extracted from blood, after activation, PRP can quickly release growth factors, which can be directly absorbed and utilized by cells and tissues to repair damage; it can inhibit the expression of inflammatory factors, increase the expression of anti-inflammatory factors, and relieve local inflammatory reactions. [0003] The source of PRP is autologous blood sep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K35/16A61K35/19A61K31/58A61K9/08A61P29/00A61P19/02A61P43/00
CPCA61K35/16A61K35/19A61K31/58A61K9/08A61K9/0019A61P29/00A61P19/02A61P43/00A61K2300/00
Inventor 靳鹏张倩邹莉蔡波
Owner 四川世纪长青干细胞生物科技发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products